Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Revvity Omics, |
RCV003140721 | SCV003818296 | uncertain significance | Emery-Dreifuss muscular dystrophy 5, autosomal dominant | 2019-10-08 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004867861 | SCV005510940 | uncertain significance | not specified | 2024-09-02 | criteria provided, single submitter | clinical testing | The c.4651A>G (p.I1551V) alteration is located in exon 32 (coding exon 31) of the SYNE2 gene. This alteration results from a A to G substitution at nucleotide position 4651, causing the isoleucine (I) at amino acid position 1551 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |